Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera
Pfizer’s offer of up to $86.25 in cash for each share of obesity drugs developer…
Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera
Pfizer’s offer of up to $86.25 in cash for each share of obesity drugs developer Metsera share tops the up to $86.20 Novo Nordisk was willing to pay. The financial consideration and the greater certainly of a deal close tipped the balance in Pfizer’s favor, ending a bidding war for Metsera and its next-generation obesity…
Understanding Various Measures to Assess Hospital Finances: A Cheat Sheet
This one-page fact sheet provides basic information for understanding measures of hospital finances. It describes profits margins and other common measures of hospitals’ financial well-being, as well as considerations when evaluating reports of these measures, such as how different approaches can make these measures appear higher or lower.
Stronger Data Governance and Reliability Standards Needed for Wearables to Power Tech-Enabled Care
To shift wearables from wellness tools to useful drivers of disease management, the data they generate must be as trustworthy as it is plentiful. Clear frameworks that govern how information is gathered and used are needed, along with standards for the accuracy and reliability of devices The post Stronger Data Governance and Reliability Standards Needed…
More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases
We urgently need biomarkers that are sensitive, objective, and practical. Eye-movement measures are ready to fill this gap, not as distant innovations, but as tools available today. The post More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases appeared first on MedCity News.
How should managed care pharmacists work improve patient engagement?
While for years patient engagement has been seen as a valuable, starting in 2026 this will be a legal mandate. Plans offering essential health benefits must appoint at least 1 patient representative to their pharmacy and therapeutics (P&T) committees by the start of 2026.1 After July 10, 2026, every state Medicaid program must establish standalone Beneficiary…
Journalists Shed Light on Opioid Settlement Cash, New Medicaid Work Requirements
KFF Health News senior correspondent Aneri Pattani discussed how states are using opioid settlement money on CBS News 24/7’s “The Daily Report” on Nov. 3. Click here to watch Pattani on “The Daily Report.” Read Pattani’s “From Narcan to Gun Silencers, Opioid Settlement Cash Pays Law Enforcement Tabs” and “Sock Hops and Concerts: How Some…
Carrum Health Expands SUD Treatment Program to Include Nearly All Substances
Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants. The post Carrum Health Expands SUD Treatment Program to Include Nearly All Substances appeared first on MedCity News.
FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest
The six new drugs awarded FDA Commissioner’s National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to “within months.” The post FDA Adds 6 More Meds to Pilot Program for…
How One Company Aims to Fix the Prosthetic Fitting Process
HumoTech has developed a robotic platform that lets patients quickly trial multiple prosthetic or exoskeleton options in a clinic, using both objective data and patient feedback to identify the best fit. The technology aims to reduce device abandonment and improve outcomes. The post How One Company Aims to Fix the Prosthetic Fitting Process appeared first…
Narcan, Drones, and Concerts: How Governments Spent Opioid Settlement Windfalls
Twenty-two million dollars to repay loans for people working in the addiction field. About $12,000 for gun silencers. Sixteen dollars for a children’s book about Spookley the Square Pumpkin. The purchases varied widely but they all came from the same source: opioid settlement money. The cash, which comes from companies accused of fueling the overdose…
